Calamp Corp. (CAMP)

$10.59

+0.09

(+0.86%)

Market is closed - opens 8 PM, 11 Nov 2024

Performance

  • $9.35
    $10.60
    $10.59
    downward going graph

    11.71%

    Downside

    Day's Volatility :11.78%

    Upside

    0.08%

    downward going graph
  • $0.65
    $12.30
    $10.59
    downward going graph

    93.86%

    Downside

    52 Weeks Volatility :94.72%

    Upside

    13.9%

    downward going graph

Returns

PeriodCalamp Corp.Sector (Technology)Index (Russel 2000)
3 Months
-1.21%
15.3%
0.0%
6 Months
170.33%
15.4%
0.0%
1 Year
49.54%
32.1%
0.0%
3 Years
-95.56%
44.1%
-26.0%

Highlights

Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
0.0%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
0.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0

Analyst Recommendation

Sell
    11%Buy
    44%Hold
    44%Sell
Based on 9 Wall street analysts offering stock ratings for Calamp Corp.(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
4
4
4
Sell
4
4
4

Analyst Forecast

What analysts predicted

Downside of 83.29%

Current $10.59
Target $1.77

Company Financials

FY21Y/Y Change
Revenue
295.8M
↓ 4.13%
Net Income
-31.1M
↑ 47.22%
Net Profit Margin
-10.53%
↓ 3.67%
FY22Y/Y Change
Revenue
294.9M
↓ 0.3%
Net Income
-32.5M
↑ 4.31%
Net Profit Margin
-11.02%
↓ 0.49%
FY22Y/Y Change
Revenue
294.9M
↓ 0.3%
Net Income
-32.5M
↑ 4.31%
Net Profit Margin
-11.02%
↓ 0.49%
FY23Y/Y Change
Revenue
186.2M
↓ 36.86%
Net Income
-93.3M
↑ 187.05%
Net Profit Margin
-50.08%
↓ 39.06%
FY23Y/Y Change
Revenue
186.2M
↓ 36.86%
Net Income
-93.3M
↑ 187.05%
Net Profit Margin
-50.08%
↓ 39.06%
FY24Y/Y Change
Revenue
186.2M
↑ 0.0%
Net Income
-93.3M
↑ 0.0%
Net Profit Margin
-50.08%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
70.9M
↑ 0.0%
Net Income
-4.0M
↑ 0.0%
Net Profit Margin
-5.69%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
70.9M
↑ 0.0%
Net Income
-4.0M
↑ 0.0%
Net Profit Margin
-5.69%
↑ 0.0%
Q3 FY23Q/Q Change
Revenue
61.7M
↑ 0.0%
Net Income
-4.2M
↑ 0.0%
Net Profit Margin
-6.85%
↑ 0.0%
Q3 FY23Q/Q Change
Revenue
61.7M
↑ 0.0%
Net Income
-4.2M
↑ 0.0%
Net Profit Margin
-6.85%
↑ 0.0%
Q4 FY23Q/Q Change
Revenue
53.6M
↑ 0.0%
Net Income
-85.0M
↑ 0.0%
Net Profit Margin
-158.52%
↑ 0.0%
Q4 FY23Q/Q Change
Revenue
53.6M
↑ 0.0%
Net Income
-85.0M
↑ 0.0%
Net Profit Margin
-158.52%
↑ 0.0%
FY21Y/Y Change
Total Assets
391.6M
↓ 9.73%
Total Liabilities
316.2M
↓ 6.65%
FY22Y/Y Change
Total Assets
380.1M
↓ 2.93%
Total Liabilities
365.8M
↑ 15.7%
FY22Y/Y Change
Total Assets
380.1M
↓ 2.93%
Total Liabilities
365.8M
↑ 15.7%
FY23Y/Y Change
Total Assets
380.1M
↑ 0.0%
Total Liabilities
365.8M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
372.2M
↑ 0.0%
Total Liabilities
359.8M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
372.2M
↑ 0.0%
Total Liabilities
359.8M
↑ 0.0%
Q3 FY23Q/Q Change
Total Assets
363.9M
↑ 0.0%
Total Liabilities
353.4M
↑ 0.0%
Q3 FY23Q/Q Change
Total Assets
363.9M
↑ 0.0%
Total Liabilities
353.4M
↑ 0.0%
Q4 FY23Q/Q Change
Total Assets
281.2M
↑ 0.0%
Total Liabilities
355.4M
↑ 0.0%
Q4 FY23Q/Q Change
Total Assets
281.2M
↑ 0.0%
Total Liabilities
355.4M
↑ 0.0%
FY21Y/Y Change
Operating Cash Flow
28.6M
↑ 0.0%
Investing Cash Flow
-13.7M
-
Financing Cash Flow
-27.3M
↑ 0.0%
FY22Y/Y Change
Operating Cash Flow
-4.2M
↑ 0.0%
Investing Cash Flow
-7.6M
-
Financing Cash Flow
-2.6M
↑ 0.0%
FY23Y/Y Change
Operating Cash Flow
-22.9M
↑ 0.0%
Investing Cash Flow
-11.1M
-
Financing Cash Flow
-909.0K
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-3.0M
↑ 173.14%
Investing Cash Flow
-2.0M
-
Financing Cash Flow
-257.0K
↓ 197.35%
Q3 FY23Q/Q Change
Operating Cash Flow
7.1M
↓ 339.7%
Investing Cash Flow
-1.9M
-
Financing Cash Flow
-114.0K
↓ 55.64%

Technicals Summary

Sell

Neutral

Buy

Calamp Corp. is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Calamp Corp.
Calamp Corp.
-1.21%
170.33%
49.54%
-95.56%
-95.66%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-17.08%
-14.93%
3.69%
33.14%
140.62%
Biontech Se
Biontech Se
-6.53%
20.69%
11.13%
-53.0%
460.49%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-0.43%
84.38%
71.37%
57.41%
200.09%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
8.52%
22.22%
38.3%
174.99%
155.94%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Calamp Corp.
Calamp Corp.
NA
NA
NA
0.0
0.0
0.0
NA
NA
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
20.41
20.41
1.2
44.89
0.17
0.07
NA
272.04
Biontech Se
Biontech Se
160.8
NA
0.04
-3.1
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-1.87
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.27
0.19
-0.03
0.13
NA
60.66
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Calamp Corp.
Calamp Corp.
Sell
$660.3K
-95.66%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$90.6B
140.62%
20.41
33.61%
Biontech Se
Biontech Se
Buy
$25.9B
460.49%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$35.1B
200.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$128.9B
155.94%
32.84
-4.51%

Insights on Calamp Corp.

  • Decreasing Revenue

    Revenue is down for the last 9 quarters, 78.88M → 53.62M (in $), with an average decrease of 4.5% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 5 quarters, -4.03M → -85.00M (in $), with an average decrease of 479.2% per quarter

  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.4% return, outperforming this stock by 21.9%

  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 57.4% return, outperforming this stock by 153.0%

Institutional Holdings

  • West Paces Advisors Inc

    0.01%

Company Information

calamp (nasdaq: camp) is leading the internet of things revolution with its extensive portfolio of intelligent communications devices, robust and capable cloud platform, and targeted software applications. calamp enables customers to optimize operations by collecting, monitoring and efficiently reporting business-critical data and desired intelligence from high-value remote assets. with a heritage in the m2m market, calamp has more than five million devices connected to its iot cloud. partners across transportation, oil and gas, and public safety markets leverage calamp to effectively gather mission- and business-critical data to make intelligent, actionable decisions. for more information, please visit www.calamp.com.

Organization
Calamp Corp.
Employees
58
CEO
Mr. Joshua Mandel-Brehm
Industry
Telecommunications Equipment

FAQs